Francesco Carrieri in an archive photo

  • Rome, murder Michela Di Pompeo: condemned to 30 years the companion Francesco Carrieri

Share

28 November 2019Francesco Carrieri, at the time when, in May 2017, he killed his companion, he was mentally ill. For this reason, he was sentenced to 16 years of imprisonment - in fact halving the sentence compared to the 30 years inflicted in the first degree - and to three years of Rems (reception facility for prisoners suffering from mental and socially dangerous disorders who replaced the old judicial psychiatric hospitals) subject to expiation.

The sentence was issued by the first Court of Assizes of Appeal of Rome, whose judges recognized for the man the diminishing of the partial defect of equivalent mind.

In the trial of the first degree the Prosecutor had pushed for the attenuator of the mental semi-infirmity of Carrieri in relation to a bipolar disorder, mixed with depression, emerged during the investigations and highlighted by technical consultants Stefano Ferracuti and Maurizio Marasco.

The PM Pantaleo Polifemo, however, had revised his position and solicited 30 years in prison because the expert appointed by the Gup, Gianluca Somma, had expressed himself for the "ability of Carrieri to understand and to want at the moment of the fact" and therefore , when Michela Di Pompeo was murdered, the man was "lucid and alert".

On appeal, however, it was decided to entrust the task to other experts, psychiatrists Gabriele Sani and Massimo Di Genio, who, investigating the accused's past, identified the first depressive symptoms in the period of separation from his wife, whose problems in the workplace would have been added.

The experts' conclusion in the Appeal process was that Carrieri, when he killed his partner, "was in conditions that at least greatly diminished the ability to understand and want". And, by virtue of the care he has sustained in prison in the last two years, "social danger can be excluded in a psychiatric sense, provided that he does not interrupt the therapy".